Search results for " Mortality"

showing 10 items of 702 documents

Serum uric acid and fatal myocardial infarction: Detection of prognostic cut-off values: The URRAH (Uric Acid Right for Heart Health) study

2019

Supplemental Digital Content is available in the text

AdultMalemedicine.medical_specialtyAdolescentPhysiologycut-off value030204 cardiovascular system & hematology03 medical and health scienceschemistry.chemical_compoundYoung Adult0302 clinical medicineuric acidInternal medicineInternal MedicinemedicineORIGINAL PAPERS: EpidemiologyHumanssex030212 general & internal medicineHyperuricemiaMyocardial infarctionRisk factorAgedAged 80 and overuric acid cardiovascular arterial hypertensioncut-off value mortality myocardial infarctionsex uric acidProportional hazards modelbusiness.industrycut-off value mortality myocardial infarction sex uric acidHazard ratioMiddle Agedmedicine.diseasePrognosismortalityConfidence intervalUric acid myocardial infarction epidemiologymyocardial infarctionchemistryItalyHypertensionComputingMethodologies_DOCUMENTANDTEXTPROCESSINGcut-off value; mortality; myocardial infarction; sex; uric acidUric acidFemaleCardiology and Cardiovascular MedicinebusinessCohort study
researchProduct

Trends in excess mortality in follicular lymphoma at a population level

2015

Background Since the 1990s and since the development of humanised monoclonal antibodies in 1998, the treatment of non-Hodgkin lymphoma has undergone profound changes. Follicular lymphoma (FL) was the first to benefit from this treatment, and several clinical trials have shown a significant improvement in overall survival, but little information is available at a population level. Objective Our objective was to estimate changes in FL-specific mortality at a population level, with an appropriate methodology. Methods Two French retrospective population-based studies on FL were conducted, one from 1995 to 2004, in 1477 patients, and one from 1995 to 2010, in 451 patients. Trends in excess morta…

AdultMalemedicine.medical_specialtyAdolescentPopulation level[SDV]Life Sciences [q-bio]PopulationFollicular lymphomaHistory 21st CenturyYoung Adult03 medical and health sciences0302 clinical medicineInternal medicineHumansMedicineIn patientRegistriesAge of OnsetStage (cooking)educationLymphoma FollicularAgedNeoplasm StagingRetrospective StudiesAged 80 and overExcess mortalityeducation.field_of_studybusiness.industryHematologyGeneral MedicineHistory 20th CenturyMiddle Agedmedicine.disease3. Good healthLymphomaClinical trialPopulation Surveillance030220 oncology & carcinogenesisImmunologyFemaleFrancebusiness030215 immunology
researchProduct

Long-term outcomes of patients with cerebral vein thrombosis: a multicenter study.

2012

Summary.  Background:  Little information is available on the long-term clinical outcome of cerebral vein thrombosis (CVT). Objectives and methods:  In an international, retrospective cohort study, we assessed the long-term rates of mortality, residual disability and recurrent venous thromboembolism (VTE) in a cohort of patients with a first CVT episode. Results:  Seven hundred and six patients (73.7% females) with CVT were included. Patients were followed for a total of 3171 patient-years. Median follow-up was 40 months (range 6, 297 months). At the end of follow-up, 20 patients had died (2.8%). The outcome was generally good: 89.1% of patients had a complete recovery (modified Rankin Scor…

AdultMalemedicine.medical_specialtyAnticoagulant treatment; Cerebral vein thrombosis; Mortality; Recurrence; Adult; Cerebral Veins; Cohort Studies; Female; Humans; Male; Middle Aged; Recurrence; ThrombosisCohort StudiesAnticoagulant treatment; Cerebral vein thrombosis; Mortality; RecurrenceRecurrenceInternal medicinemedicineRisk of mortalityHumansMED/41 - ANESTESIOLOGIAMortalitybusiness.industryIncidence (epidemiology)Cerebral Vein thrombosiHazard ratioCerebral VeinRetrospective cohort studyThrombosisHematologyMiddle Agedmedicine.diseaseThrombosisCerebral VeinsConfidence intervalSurgerycerebral vein thrombosisSettore MED/15 - MALATTIE DEL SANGUEThrombosiCohortFemaleAnticoagulant treatmentCohort StudiebusinessHumanCohort studyJournal of thrombosis and haemostasis : JTH
researchProduct

Reperfusion therapy for ST elevation acute myocardial infarction 2010/2011:current status in 37 ESC countries

2014

Item does not contain fulltext AIMS: Primary percutaneous coronary intervention (PPCI) is the preferred reperfusion therapy in ST-elevation myocardial infarction (STEMI). We conducted this study to evaluate the contemporary status on the use and type of reperfusion therapy in patients admitted with STEMI in the European Society of Cardiology (ESC) member countries. METHODS AND RESULTS: A cross-sectional descriptive study based on aggregated country-level data on the use of reperfusion therapy in patients admitted with STEMI during 2010 or 2011. Thirty-seven ESC countries were able to provide data from existing national or regional registries. In countries where no such registries exist, dat…

AdultMalemedicine.medical_specialtyCross-sectional studymedicine.medical_treatmentVascular damage Radboud Institute for Health Sciences [Radboudumc 16]PopulationCardiologyMyocardial Infarctionacute myocardial infarction610 Medicine & healthMyocardial ReperfusionPercutaneous Coronary InterventionReperfusion therapyHumansMedicineThrombolytic TherapyIn patientHospital MortalityRegistriescardiovascular diseasesMyocardial infarctioneducationAgededucation.field_of_studybusiness.industryST elevationCoronary Care UnitsPercutaneous coronary interventionThrombolysisMiddle Agedmedicine.disease3. Good healthEuropeCross-Sectional Studiessurgical procedures operativeEmergency medicineWorkforceFemaleHuman medicineMedical emergencyCardiology and Cardiovascular Medicinebusiness
researchProduct

Carcinoma of the hypopharynx and the cervical oesophagus: a surgical challenge.

1999

To report our results after reconstruction of the upper digestive tract for locally advanced carcinoma of the hypopharynx and cervical oesophagus.Open study.Teaching University hospital, Germany.Of the 517 patients who presented with carcinoma of the oesophagus between September 1985 and March 1997, 16 had a locally advanced tumour of the hypopharynx and 25 of the cervical oesophagus.Free jejunal grafts were used after circular resection in all patients with carcinoma of the hypopharynx, and for the 3 with oesophageal carcinoma in whom we obtained adequate resection margins. In the remainder stomach was used in 21 and colon in 1.Morbidity and mortality.After jejunal grafting 1 patient died …

AdultMalemedicine.medical_specialtyEsophageal Neoplasmsmedicine.medical_treatmentAnastomosisAdenocarcinomaEsophagusPostoperative ComplicationsHypopharyngeal Neoplasmotorhinolaryngologic diseasesmedicineCarcinomaHumansHospital MortalityEsophagusSurvival rateNeoplasm StagingHypopharyngeal Neoplasmsbusiness.industryStomachdigestive oral and skin physiologyMiddle Agedmedicine.diseaseSurgeryEsophagectomySurvival RateHypopharynxmedicine.anatomical_structureJejunumEsophagectomyCarcinoma Squamous CellAdenocarcinomaSurgeryFemalebusinessThe European journal of surgery = Acta chirurgica
researchProduct

Deaths Associated with Ankylosing Spondylitis in France from 1969 to 2009.

2017

Objective.To describe deaths for which ankylosing spondylitis (AS) was on death certificates in France.Methods.Death certificates in which AS was indicated were evaluated. Standard mortality ratio (SMR) was assessed.Results.AS appeared in 2940 death certificates. The mortality rate of AS seemed stable. The most frequent initial causes were diseases of the circulatory system [28.3% in the International Classification of Diseases, 10th ed (ICD-10)]. SMR adjusted for age and sex were 2.1 (95% CI 1.45–2.91) for infections and 0.43 (0.36–0.5) for cancers (ICD-10 period).Conclusion.This study found an increase in mortality from infectious and external causes of death; conversely, patients with AS…

AdultMalemedicine.medical_specialtyImmunologyAge and sexDeath Certificates03 medical and health sciences0302 clinical medicineRheumatologyInternal medicineCause of DeathmedicineImmunology and AllergyHumansSpondylitis Ankylosing030212 general & internal medicineAged030203 arthritis & rheumatologyAged 80 and overAnkylosing spondylitisbusiness.industryMortality rateCancerMiddle Agedmedicine.diseaseSurgeryStandardized mortality ratioFemaleDeath certificateFrancebusinessThe Journal of rheumatology
researchProduct

Influence of social factors on avoidable mortality: a hospital-based case-control study.

2005

Objective. The effect of socioeconomic factors on avoidable mortality at an individual level is not well known, since most studies showing this association are based on aggregate data. The purpose of this study was to determine socioeconomic differences between those patients who die of avoidable causes and those who do not die. Methods. A matched case-control study was carried out regarding in-hospital avoidable mortality (Holland's medical care indicators) that occurred in a university hospital serving a Spanish-Mediterranean population during a 30-month period. Results. We studied 82 cases of death from avoidable causes and 300 controls matched on medical care indicators and age. The var…

AdultMalemedicine.medical_specialtyPediatricsAdolescentMatched-Pair AnalysisPopulationLower risk03 medical and health sciences0302 clinical medicineRisk FactorsCause of DeathEpidemiologymedicineHumans030212 general & internal medicineHospital MortalityeducationChildSocioeconomic statuseducation.field_of_study030505 public healthbusiness.industryPublic healthPublic Health Environmental and Occupational HealthCase-control studyInfant NewbornInfantOdds ratioMiddle AgedLogistic ModelsSocioeconomic FactorsSpainCase-Control StudiesChild PreschoolMultivariate AnalysisEducational StatusAggregate dataFemale0305 other medical sciencebusinessDemographyResearch ArticlePublic health reports (Washington, D.C. : 1974)
researchProduct

Mortality in the first 30 days following incident acute symptomatic seizures.

2005

Purpose: Very little is known about short-term mortality after acute symptomatic seizure. One study found an increased mortality in the first year after acute symptomatic seizure, like mortality following acute symptomatic status epilepticus. Methods: We studied mortality in the first 30 days after an acute symptomatic seizure in two cohorts. In Washington Heights, New York City, we reviewed the medical records of all adults aged 20 years and older seen at Columbia Presbyterian Medical Center from January 1, 1990 through December 13, 1994 to identify incident acute symptomatic seizure. In Rochester, Minnesota, the medical records of all Rochester residents were reviewed to identify incident…

AdultMalemedicine.medical_specialtyPediatricsMinnesotaComorbidityCohort StudiesEpilepsyCause of DeathCase fatality ratemedicineHumansMortalityCause of deathAgedEpilepsybusiness.industryIncidence (epidemiology)IncidenceSymptomatic seizuresMiddle Agedmedicine.diseaseSurgeryStandardized mortality ratioNeurologyAcute DiseaseEtiologyFemaleNew York CityNeurology (clinical)businessCohort studyFollow-Up StudiesEpilepsia
researchProduct

Picotamide, a combined inhibitor of thromboxane A2 synthase and receptor, reduces 2-year mortality in diabetics with peripheral arterial disease: the…

2004

Aims Patients with diabetes are at excessive risk of mortality and cardiovascular morbidity. Previous studies suggest that aspirin may be less effective in diabetic patients. In this multi-centre, randomized, double blind trial picotamide, a dual inhibitor of thromboxane A2 synthase and receptor, was compared with aspirin for the prevention of mortality and major cardiovascular events in diabetics with peripheral arterial disease (PAD). Methods and results A total of 1209 adults aged 40–75 years with type 2 diabetes and PAD were randomized to receive picotamide (600 mg bid) or aspirin (320 mg od) for 24 months. The cumulative incidence of the 2 years overall mortality was significantly lowe…

AdultMalemedicine.medical_specialtyPhthalic AcidsType 2 diabetesDiabeteGastroenterologyThromboxane A2Double-Blind MethodRisk FactorsInternal medicineDiabetes mellitusPeripheral arterial diseasemedicineRisk of mortalityHumansPicotamideCumulative incidenceGeneral NursingAgedPeripheral Vascular DiseasesAspirinAspirinbiologybusiness.industryAntiplatelet therapyantiplatelet therapy; aspirin; diabetes; peripheral arterial disease; picotamide; thromboxane synthase inhibitorsMiddle Agedmedicine.diseaseSurvival AnalysisSurgeryThromboxane synthase inhibitors Indexed keywordsRelative riskbiology.proteinFemaleThromboxane-A synthasePicotamideCardiology and Cardiovascular MedicinebusinessDiabetic AngiopathiesPlatelet Aggregation InhibitorsFollow-Up Studiesmedicine.drugEuropean Heart Journal
researchProduct

Syncope in the German Nationwide inpatient sample – Syncope in atrial fibrillation/flutter is related to pulmonary embolism and is accompanied by hig…

2019

Syncope is a common phenomenon in the general population. Although most of the causes are of benign origin, some comorbidities are accompanied by high mortality. We aimed to compare the in-hospital mortality of patients with syncope related to different comorbities and investigate the impact of syncope in patients with atrial fibrillation/flutter (AF).The nationwide inpatient sample of Germany of the years 2011-2014 was used for this analysis. Patients with syncope (ICD-code R55) were stratified by presence of selected comorbidities. Additionally, AF patients with and without syncope were compared. Incidence of syncope and in-hospital mortality were calculated. Syncope as a predictor of adv…

AdultMalemedicine.medical_specialtyPopulationMyocardial InfarctionComorbidity030204 cardiovascular system & hematologySyncopeYoung Adult03 medical and health sciences0302 clinical medicineRisk FactorsCause of DeathGermanyInternal medicineAtrial FibrillationInternal MedicinemedicineHumansHospital Mortality030212 general & internal medicineMyocardial infarctioneducationStrokeAgedAged 80 and overHeart Failureeducation.field_of_studybiologybusiness.industryIncidenceMortality rateIncidence (epidemiology)Syncope (genus)Atrial fibrillationPneumoniaMiddle Agedmedicine.diseasebiology.organism_classificationPulmonary embolismStrokeLogistic ModelsMultivariate AnalysisCardiologyFemalePulmonary EmbolismbusinessEuropean Journal of Internal Medicine
researchProduct